Loading
Infection with the two virus types that cause most cervical cancer fell by 83 per cent among 17 and 18 year old South African girls after the school vaccination programme, and by a similar proportion among girls living with HIV.
South Africa began vaccinating Grade 4 girls aged 9 and over at school against HPV types 16 and 18 in 2014, reaching 87 per cent of learners with at least one of two doses. The authors invited girls aged 17 to 18 from 15 primary care clinics in Free State, Gauteng, Mpumalanga and North West to give a self-collected vaginal sample: 819 in 2019, before the vaccinated cohorts reached that age, and 1,538 in 2023, from cohorts eligible for the programme.
A two-dose school programme in a country with high HIV prevalence produced reductions in infection similar to three-dose programmes in high-income countries, including in girls living with HIV, who are at higher risk of cervical cancer.
Shares National Department of Health, South Africa, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/